Breaking News Instant updates and real-time market news.

HIMX

Himax

$8.01

-0.07 (-0.87%)

, SSNLF

Samsung

14:44
07/14/17
07/14
14:44
07/14/17
14:44

Himax issues strongly worded rebuke to analyst after downgrade

Himax Technologies (HIMX) responded to a downgrade of its stock by an analyst at Oppenheimer with a strongly worded reply, in which the company said it has not communicated with the analyst in months and questioned the timing of the report. OPPENHEIMER DOWNGRADES: Oppenheimer analyst Andrew Uerkwitz downgraded Himax to Underperform, the firm's lowest rating, with a $4 price target, saying decreased smartphone expectations in China for 2017 will weigh on the company's near-term orders. He added while he expects many new phones to be released in the second half of this year, there will be a shift to 18:9 displays, an area in which he feels Himax lags behind its competitors, and he remains hesitant on the company's Touch and Display Driver Integration, or TDDI, opportunities. Uerkwitz also said forecasts have estimated growing OLED panel shipments but Himax is unlikely to win OLED driver IC business from Samsung (SSNLF) in the near-term. The analyst believes a "smooth" turnaround for Himax's DDIC business is unlikely and notes his estimates for the company have been the lowest on Wall Street for some time. HIMAX RESPONDS: In a statement provided to The Fly, Himax said, "The management have not spoken to the analyst Andrew Uerkwitz from Oppenheimer for three months. Thus, we believe his report recently issued on July 14 is INACCURATE and MISLEADING. This report does not represent the fact of our company at all. Our business is not only on track but also rebounded strongly reflecting market share gain. We will report positively on the 2Q17 earnings call...We question Andrew Uerwitz's intention to set up a low Target Price without facts, especially when Himax just declared dividend where investors only have one week to buy to get dividend. He chose this time to publish a negative report with a ridiculous Target Price without talking to Himax management on the day we announce our EC date is also suspicious." PRICE ACTION: Himax, which spent the early part of the session in negative territory, is up 0.6% to $8.06 in afternoon trading.

HIMX

Himax

$8.01

-0.07 (-0.87%)

SSNLF

Samsung

  • 03

    Aug

  • 05

    Sep

HIMX Himax
$8.01

-0.07 (-0.87%)

07/14/17
07/14/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Snap (SNAP) downgraded to Market Perform from Outperform at Cowen with analyst John Blackledge lowering his 2017 and longer-term advertising revenue estimates for Snap to reflect a more competitive environment within Digital advertising. He also believes contribution from the company's new advertising monetization products like Direct Response and Self Serve are not likely to be meaningful in the near term. 2. CyberArk (CYBR) was downgraded to Equal Weight from Overweight at Stephens, to Hold from Buy at Deutsche Bank, and to Neutral from Overweight at JPMorgan. 3. At Home Group (HOME) downgraded to Neutral from Buy at Goldman Sachs with analyst Matthew Fassler citing valuation with the shares up 82% since his upgrade to Buy on November 30, 2016. 4. A10 Networks (ATEN) downgraded to Sector Weight from Overweight at KeyBanc with analyst Alex Kurtz citing "substantially" lower projected growth rates following the company's weaker than expected preliminary second quarter results. 5. Himax (HIMX) downgraded to Underperform from Perform at Oppenheimer with analyst Andrew Uerkwitz saying lowered smartphone expectations in China for 2017 will weigh on the company's near-term orders. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/14/17
OPCO
07/14/17
DOWNGRADE
OPCO
Underperform
Himax downgraded to Underperform from Perform at Oppenheimer
Oppenheimer analyst Andrew Uerkwitz downgraded Himax Technologies to Underperform with a $4 price target. Lowered smartphone expectations in China for 2017 will weigh on the company's near-term orders, Uerkwitz tells investors in a research note. The analyst believes a "smooth" turnaround for Himax's DDIC business is unlikely and notes his estimates for the company have been Street-low for some time.
07/11/17
NORL
07/11/17
NO CHANGE
NORL
Outperform
Himax could see some near-term revenue weakness, says Northland
Northland analyst Tome Sepenzis said a number of Chinese handset OEM's have slowed down new ordering, particularly in the TDDI segment. The analyst believes there could be some near-term weakness in the small/medium driver business with a pick up later in the year. As a result, Sepenzi believes Himax could report June revenues in the low $150M range, versus consensus of $153M, with potential September guidance lower as well. If the stock weakens in the near-term, Sepenzis would use it as a buying opportunity and reiterates his Outperform rating and $10 price target on Himax.
05/11/17
LSCM
05/11/17
DOWNGRADE
LSCM
Hold
Himax downgraded to Hold from Buy at Lake Street
SSNLF Samsung

07/07/17
ADAM
07/07/17
NO CHANGE
Target $180
ADAM
Buy
Apple iPhone sales improved later in the quarter, says Canaccord
Canaccord Genuity analyst T. Michael Walkley says his firm's June North American smartphone surveys indicated "steady" sales of Apple's (AAPL) iPhone 7 through the June quarter. Sales were "stable to improving" later in the quarter as enthusiasm for Samsung's (SSNLF) Galaxy S8 waned in the U.S. market, Walkley tells investors in a research note. The analyst adds that his iPhone unit estimates for the June and September quarters are consistent with consensus expectations at 42M and 47M units, respectively. He expects a stronger iPhone upgrade cycle in 2018 with the 10-year anniversary iPhone 8. The analyst reiterates a Buy rating on Apple with a $180 price target. The iPhone maker closed yesterday down $1.36 to $142.73.
05/17/17
MSCO
05/17/17
NO CHANGE
Target $177
MSCO
Overweight
Apple target raised to $177 at Morgan Stanley after survey shows rising loyalty
Morgan Stanley analyst Katy Huberty reported that the firm's recent survey of 1,000 U.S. consumers shows a rising iPhone retention rate, with 92% of iPhone owners who see upgrading their phone in the next 12 months saying they plan to stick to an iPhone, up from the 86% retention rate in last year's survey. Apple's (AAPL) 92% loyalty rate "dwarfs" that of all other vendors, with its biggest competitor, Samsung (SSNLF), seeing a 77% retention rate, she noted. Huberty, who sees Apple being positioned to gain increasing U.S. smartphone share, raised her price target on Apple to $177 from $161 and keeps an Overweight rating on the stock.
04/28/17
CHLM
04/28/17
NO CHANGE
Target $120
CHLM
Buy
Skyworks price target raised to $120 from $110 at Craig-Hallum
Craig-Hallum analyst Anthony Stoss raised his price target for Skyworks (SWKS) to $120 from $110 after the company reported results and guidance above estimates driven by content expansion in Samsung's (SSNLF) Galaxy S8 and at Huawei, and continued strength in its Internet of Things business. The analyst reiterates a Buy rating on the shares.
04/28/17
NEED
04/28/17
NO CHANGE
Target $108
NEED
Buy
Skyworks price target raised to $108 from $92 at Needham
Needham analyst N. Quinn Bolton raised his price target for Skyworks (SWKS) to $108 from $92 after the company delivered another beat and raise quarter driven by content gains at Huawei and Samsung (SSNLF) and issued a strong outlook for the rest of 2017. The analyst reiterates a Buy rating on the Skyworks' shares.

TODAY'S FREE FLY STORIES

EGRX

Eagle Pharmaceuticals

$70.04

-2.76 (-3.79%)

12:37
07/26/17
07/26
12:37
07/26/17
12:37
Hot Stocks
Breaking Hot Stocks news story on Eagle Pharmaceuticals »

Eagle Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

EGRX

Eagle Pharmaceuticals

$70.04

-2.76 (-3.79%)

12:36
07/26/17
07/26
12:36
07/26/17
12:36
Hot Stocks
Breaking Hot Stocks news story on Eagle Pharmaceuticals »

Eagle says FDA asks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

CMG

Chipotle

$346.19

-2.427 (-0.70%)

12:36
07/26/17
07/26
12:36
07/26/17
12:36
Periodicals
Expert calls Chipotle's FDA criminal subpoena 'highly unusual,' NY Post reports »

The subpoena from the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EGRX

Eagle Pharmaceuticals

$70.04

-2.76 (-3.79%)

12:36
07/26/17
07/26
12:36
07/26/17
12:36
Hot Stocks
Eagle Pharmaceuticals receives complete response letter from FDA on Ryanodex »

Eagle Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

IVPAF

Ivanhoe Mines

$3.89

0.1263 (3.36%)

12:33
07/26/17
07/26
12:33
07/26/17
12:33
Conference/Events
Ivanhoe Mines management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

WYNN

Wynn Resorts

$138.98

0.45 (0.32%)

12:30
07/26/17
07/26
12:30
07/26/17
12:30
Options
Wynn Resorts calls active as shares fall on earnings »

Wynn Resorts calls active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EGRX

Eagle Pharmaceuticals

$70.04

-2.76 (-3.79%)

12:29
07/26/17
07/26
12:29
07/26/17
12:29
Hot Stocks
Breaking Hot Stocks news story on Eagle Pharmaceuticals »

Eagle Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

FLY

Fly Leasing

$13.94

-0.04 (-0.29%)

12:27
07/26/17
07/26
12:27
07/26/17
12:27
Conference/Events
Fly Leasing management to meet with RBC Capital »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 10

    Aug

SIRI

SiriusXM

$5.39

0.01 (0.19%)

12:25
07/26/17
07/26
12:25
07/26/17
12:25
Options
Sirius XM call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 05

    Sep

AKAM

Akamai

$53.28

0.91 (1.74%)

12:24
07/26/17
07/26
12:24
07/26/17
12:24
Conference/Events
Akamai management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 27

    Jul

  • 08

    Aug

  • 05

    Sep

MPC

Marathon Petroleum

$56.44

0.42 (0.75%)

12:20
07/26/17
07/26
12:20
07/26/17
12:20
Hot Stocks
Marathon Petroleum raises quarterly dividend 11% to 40c per share »

Marathon Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

$NSD

NASDAQ Market Internals

12:17
07/26/17
07/26
12:17
07/26/17
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
07/26/17
07/26
12:16
07/26/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSCO

Tractor Supply

$53.53

2.01 (3.90%)

12:15
07/26/17
07/26
12:15
07/26/17
12:15
Options
Tractor Supply put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

BA

Boeing

$230.75

18.29 (8.61%)

, KO

Coca-Cola

$45.36

0.1151 (0.25%)

12:03
07/26/17
07/26
12:03
07/26/17
12:03
General news
On The Fly: Top stock stories at midday »

Stocks opened in positive…

BA

Boeing

$230.75

18.29 (8.61%)

KO

Coca-Cola

$45.36

0.1151 (0.25%)

T

AT&T

$37.84

1.62 (4.47%)

AMD

AMD

$14.11

-0.05 (-0.35%)

TXN

Texas Instruments

$81.39

0.47 (0.58%)

GLW

Corning

$30.29

-1.84 (-5.73%)

GD

General Dynamics

$194.50

-9.06 (-4.45%)

AMGN

Amgen

$180.89

-0.17 (-0.09%)

IRBT

iRobot

$87.90

-2.48 (-2.74%)

AMED

Amedisys

$59.41

0.61 (1.04%)

AFAM

Almost Family

$56.70

-0.15 (-0.26%)

HLS

HealthSouth

$43.48

-2.24 (-4.90%)

KND

Kindred Healthcare

$9.70

-1.5 (-13.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 27

    Jul

  • 30

    Jul

  • 01

    Aug

  • 04

    Aug

  • 07

    Aug

  • 08

    Aug

  • 14

    Aug

  • 14

    Aug

  • 15

    Aug

  • 16

    Aug

  • 17

    Aug

  • 23

    Aug

  • 23

    Aug

  • 29

    Aug

  • 07

    Sep

  • 08

    Sep

  • 14

    Sep

  • 16

    Nov

  • 03

    Feb

  • 17

    May

GSM

Ferroglobe

$12.90

0.32 (2.54%)

12:02
07/26/17
07/26
12:02
07/26/17
12:02
Hot Stocks
Ferroglobe has not received regulatory approvals from Spain's water authority »

Ferroglobe announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

MNGA

Magnegas

$0.75

-0.1699 (-18.47%)

12:01
07/26/17
07/26
12:01
07/26/17
12:01
Hot Stocks
USPTO issues MagneGas patent on MagneCule theory »

MagneGas Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JBLU

JetBlue

$22.77

0.01 (0.04%)

12:00
07/26/17
07/26
12:00
07/26/17
12:00
Options
Post-earnings option play opened in JetBlue »

Post-earnings option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Aug

BA

Boeing

$229.65

17.1924 (8.09%)

11:54
07/26/17
07/26
11:54
07/26/17
11:54
Hot Stocks
Boeing seeing Pentagon demand above Trump's FY18 budget request »

In its Defense, Space…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 07

    Aug

WY

Weyerhaeuser

$34.11

-0.014 (-0.04%)

11:50
07/26/17
07/26
11:50
07/26/17
11:50
Options
Call buyer in Weyerhaeuser ahead of earnings »

Call buyer in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jul

LVMUY

LVMH

$51.12

-0.02 (-0.04%)

11:49
07/26/17
07/26
11:49
07/26/17
11:49
Earnings
LVMH reports first half revenue up 15% to EUR 19.7B »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$229.61

17.15 (8.07%)

11:47
07/26/17
07/26
11:47
07/26/17
11:47
Hot Stocks
Boeing has over '700 firm orders in backlog' for 787 Dreamliner program »

Boeing said its 787…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 07

    Aug

FB

Facebook

$165.28

-0.72 (-0.43%)

11:45
07/26/17
07/26
11:45
07/26/17
11:45
Technical Analysis
Technical Earnings Preview: Facebook in strong uptrend before news »

The stock has been in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 13

    Sep

CF

CF Industries

$29.01

-1.16 (-3.84%)

11:45
07/26/17
07/26
11:45
07/26/17
11:45
Options
CF Industries call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

11:45
07/26/17
07/26
11:45
07/26/17
11:45
General news
Treasury's $15 B 2-year FRN garnered decent results »

Treasury's $15 B…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.